U.S. market Closed. Opens in 1 day 3 hours 44 minutes

ATNFW | CannBioRx Life Sciences Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue105.67K109.00K116.30K125.33K72.24KN/A
Gross Profit-105.67K-109.00K-116.30K-125.33K-72.24KN/A
Operating Expenses22.24M39.64M20.16M9.82M25.22M-14.51K
Selling, General & Admin10.69M15.47M11.69M3.36M18.85M7.67K
Research & Development2.78M2.43M3.95M2.29M2.04M1.07K
Other Operating Expenses527.33B246.34B770.60K264.74K250.40KN/A
Operating Income-13.48M-17.90M-15.64M-5.65M-20.86M-8.74K
Other Expenses / Income-8.81M-21.77M-4.71M-5.26M-4.54M-5.75K
Before Tax Income-22.28M-39.67M-20.35M-10.90M-25.40M-14.49K
Income Tax Expenses2.35M942.75K23.20K20.43K9.50K46.00
Net Income-19.94M-38.73M-20.32M-12.01M-25.39M-14.49K
Interest Expenses-44.83B26.67K186.21K1.09M185.14KN/A
Basic Shares Outstanding379.00K100.00K82.00K47.00K29.00KN/A
Diluted Shares Outstanding379.09K100.02K82.51K47.77K29.04KN/A
EBITDA-13.37M-17.79M-15.53M-5.52M-20.79M-8.72K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-44.85B-37.76M-20.12M-10.90M-25.20M-14.45K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙